BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

634 related articles for article (PubMed ID: 28487370)

  • 1. Transactive response DNA-binding protein 43 (TDP-43) regulates alternative splicing of tau exon 10: Implications for the pathogenesis of tauopathies.
    Gu J; Chen F; Iqbal K; Gong CX; Wang X; Liu F
    J Biol Chem; 2017 Jun; 292(25):10600-10612. PubMed ID: 28487370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorylation of trans-active response DNA-binding protein-of 43 kDa promotes its cytoplasmic aggregation and modulates its function in tau mRNA stability and exon 10 alternative splicing.
    Wu R; Zhou D; Shen X; Chen F; Liu F; Gu J
    J Neurochem; 2021 Aug; 158(3):766-778. PubMed ID: 34107054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of alternative splicing of tau exon 10.
    Qian W; Liu F
    Neurosci Bull; 2014 Apr; 30(2):367-77. PubMed ID: 24627328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An SRp75/hnRNPG complex interacting with hnRNPE2 regulates the 5' splice site of tau exon 10, whose misregulation causes frontotemporal dementia.
    Wang Y; Wang J; Gao L; Stamm S; Andreadis A
    Gene; 2011 Oct; 485(2):130-8. PubMed ID: 21723381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurodegenerative disorder FTDP-17-related tau intron 10 +16C → T mutation increases tau exon 10 splicing and causes tauopathy in transgenic mice.
    Umeda T; Yamashita T; Kimura T; Ohnishi K; Takuma H; Ozeki T; Takashima A; Tomiyama T; Mori H
    Am J Pathol; 2013 Jul; 183(1):211-25. PubMed ID: 23680655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneous nuclear ribonucleoprotein E3 modestly activates splicing of tau exon 10 via its proximal downstream intron, a hotspot for frontotemporal dementia mutations.
    Wang Y; Gao L; Tse SW; Andreadis A
    Gene; 2010 Feb; 451(1-2):23-31. PubMed ID: 19914360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevation of casein kinase 1ε associated with TDP-43 and tau pathologies in Alzheimer's disease.
    Gu J; Hu W; Tan X; Qu S; Chu D; Gong CX; Iqbal K; Liu F
    Brain Pathol; 2020 Mar; 30(2):283-297. PubMed ID: 31376192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Robust cytoplasmic accumulation of phosphorylated TDP-43 in transgenic models of tauopathy.
    Clippinger AK; D'Alton S; Lin WL; Gendron TF; Howard J; Borchelt DR; Cannon A; Carlomagno Y; Chakrabarty P; Cook C; Golde TE; Levites Y; Ranum L; Schultheis PJ; Xu G; Petrucelli L; Sahara N; Dickson DW; Giasson B; Lewis J
    Acta Neuropathol; 2013 Jul; 126(1):39-50. PubMed ID: 23666556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TDP-43 regulates the alternative splicing of hnRNP A1 to yield an aggregation-prone variant in amyotrophic lateral sclerosis.
    Deshaies JE; Shkreta L; Moszczynski AJ; Sidibé H; Semmler S; Fouillen A; Bennett ER; Bekenstein U; Destroismaisons L; Toutant J; Delmotte Q; Volkening K; Stabile S; Aulas A; Khalfallah Y; Soreq H; Nanci A; Strong MJ; Chabot B; Vande Velde C
    Brain; 2018 May; 141(5):1320-1333. PubMed ID: 29562314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of association between TDP-43 pathology and tau mis-splicing in Alzheimer's disease.
    Niblock M; Hortobágyi T; Troakes C; Al-Sarraj S; Spickett C; Jones R; Shaw CE; Gallo JM
    Neurobiol Aging; 2016 Jan; 37():45-46. PubMed ID: 26507309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclic AMP-dependent protein kinase regulates the alternative splicing of tau exon 10: a mechanism involved in tau pathology of Alzheimer disease.
    Shi J; Qian W; Yin X; Iqbal K; Grundke-Iqbal I; Gu X; Ding F; Gong CX; Liu F
    J Biol Chem; 2011 Apr; 286(16):14639-48. PubMed ID: 21367856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Motor neuron TDP-43 proteinopathy in progressive supranuclear palsy and corticobasal degeneration.
    Riku Y; Iwasaki Y; Ishigaki S; Akagi A; Hasegawa M; Nishioka K; Li Y; Riku M; Ikeuchi T; Fujioka Y; Miyahara H; Sone J; Hattori N; Yoshida M; Katsuno M; Sobue G
    Brain; 2022 Aug; 145(8):2769-2784. PubMed ID: 35274674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tau Interacting Proteins: Gaining Insight into the Roles of Tau in Health and Disease.
    Stancu IC; Ferraiolo M; Terwel D; Dewachter I
    Adv Exp Med Biol; 2019; 1184():145-166. PubMed ID: 32096036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual-specificity tyrosine phosphorylation-regulated kinase 1A (Dyrk1A) modulates serine/arginine-rich protein 55 (SRp55)-promoted Tau exon 10 inclusion.
    Yin X; Jin N; Gu J; Shi J; Zhou J; Gong CX; Iqbal K; Grundke-Iqbal I; Liu F
    J Biol Chem; 2012 Aug; 287(36):30497-506. PubMed ID: 22767602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of Tau Isoforms Imbalance Precludes Tau Pathology and Cognitive Decline in a Mouse Model of Tauopathy.
    Espíndola SL; Damianich A; Alvarez RJ; Sartor M; Belforte JE; Ferrario JE; Gallo JM; Avale ME
    Cell Rep; 2018 Apr; 23(3):709-715. PubMed ID: 29669277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SIRT1 Deacetylates SC35 and Suppresses Its Function in Tau Exon 10 Inclusion.
    Yin X; Jiang X; Wang J; Qian S; Liu F; Qian W
    J Alzheimers Dis; 2018; 61(2):561-570. PubMed ID: 29226865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TDP-43 and Tau Oligomers in Alzheimer's Disease, Amyotrophic Lateral Sclerosis, and Frontotemporal Dementia.
    Montalbano M; McAllen S; Cascio FL; Sengupta U; Garcia S; Bhatt N; Ellsworth A; Heidelman EA; Johnson OD; Doskocil S; Kayed R
    Neurobiol Dis; 2020 Dec; 146():105130. PubMed ID: 33065281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative analysis of tau isoform transcripts in sporadic tauopathies.
    Connell JW; Rodriguez-Martin T; Gibb GM; Kahn NM; Grierson AJ; Hanger DP; Revesz T; Lantos PL; Anderton BH; Gallo JM
    Brain Res Mol Brain Res; 2005 Jun; 137(1-2):104-9. PubMed ID: 15950767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolution of neuronal and glial tau isoforms in chronic traumatic encephalopathy.
    Cherry JD; Kim SH; Stein TD; Pothast MJ; Nicks R; Meng G; Huber BR; Mez J; Alosco ML; Tripodis Y; Farrell K; Alvarez VE; McKee AC; Crary JF
    Brain Pathol; 2020 Sep; 30(5):913-925. PubMed ID: 32500646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternative splicing of exon 10 in the tau gene as a target for treatment of tauopathies.
    Zhou J; Yu Q; Zou T
    BMC Neurosci; 2008 Dec; 9 Suppl 2(Suppl 2):S10. PubMed ID: 19090983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.